AHA today urged the Centers for Medicare & Medicaid Services to reverse its policy prohibiting pass-through payments to hospitals through the Medicaid managed care system, and work with states and hospitals “to explore how these vital funds can support state payment and delivery reform objectives, such as value-based payment arrangements.” A 2016 final rule effectively ended these supplemental payments for hospitals in a managed care setting. AHA voiced support for many of the rule’s other policy changes, such as standardizing requirements for the state capitation rate setting process and health plan medical loss ratios, provider network adequacy standards and strategies for quality improvement. AHA also supports the provision allowing states to pay a capitated payment to managed care plans for enrollees aged 21 to 64 who are subject to the Medicaid Institutions for Mental Disease exclusion, but urged the agency to consider expanding the 15-day limit on enrollees’ stay. “There is a critical need to improve access to short-term inpatient psychiatric and substance use disorder treatment for the Medicaid population,” wrote Ashley Thompson, AHA senior vice president of public policy analysis and development.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services April 19 approved an amendment to a Massachusetts Medicaid and Children’s Health Insurance Program…
Headline
One in five Medicaid enrollees have been disenrolled since continuous coverage ended last March, a quarter of whom remain uninsured, according to a poll…
Headline
The Centers for Medicare & Medicaid Services March 28 announced an extension of its temporary Marketplace special enrollment period for those who lost…
Headline
The Centers for Medicare & Medicaid Services March 15 announced flexibilities to help states initiate interim Medicaid payments to health care providers…
Headline
The Senate voted 75-22 on March 8 to pass and send to the president for his signature a package of six appropriations bills funding certain federal agencies…
Headline
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies…